Skip to main content

Abbott Laboratories Medical Devices revenue

  • ABT · NYSE
  • Pharmaceuticals
  • Health Care Equipment
  • S&P 500
$108.52+1.18%Close 13 Nov 2026 · Market value $187.6B

Medical Devices revenue at Abbott Laboratories came to $5.8B for the quarter to 30 Sep 2026, up 6.9% from a year earlier.

As Abbott Laboratories reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 4 Nov 2026.

By quarter

$4.4BDec 2023$4.5BMar 2024$4.7BJun 2024$4.7BSep 2024$5.1BDec 2024$4.9BMar 2025$5.4BJun 2025$5.4BSep 2025$5.7BDec 2025$5.5BMar 2026$5.9BJun 2026$5.8BSep 2026
Abbott Laboratories Medical Devices revenue, every reported period
Period endingMedical Devices revenueChange on a yearFiled
30 Sep 2026$5.8Bup 6.9%4 Nov 2026
30 Jun 2026$5.9Bup 9.0%28 Jul 2026
31 Mar 2026$5.5Bup 13.2%29 Apr 2026
31 Dec 2025$5.7Bup 12.3%20 Feb 2026
30 Sep 2025$5.4Bup 14.8%29 Oct 2025
30 Jun 2025$5.4Bup 13.4%30 Jul 2025
31 Mar 2025$4.9Bup 9.9%30 Apr 2025
31 Dec 2024$5.1Bup 13.7%21 Feb 2025
30 Sep 2024$4.7Bup 11.7%31 Oct 2024
30 Jun 2024$4.7Bup 10.2%31 Jul 2024
31 Mar 2024$4.5Bup 14.2%2 May 2024
31 Dec 2023$4.4Bup 17.6%16 Feb 2024
30 Sep 2023$4.2Bup 16.6%1 Nov 2023
30 Jun 2023$4.3Bup 13.5%3 Aug 2023
31 Mar 2023$3.9Bup 8.5%4 May 2023
31 Dec 2022$3.8Bup 0.8%17 Feb 2023
30 Sep 2022$3.6Bup 0.4%1 Nov 2022
30 Jun 2022$3.8Bup 3.2%2 Aug 2022
31 Mar 2022$3.6Bup 8.3%3 May 2022
31 Dec 2021$3.7Bup 15.1%18 Feb 2022
30 Sep 2021$3.6Bup 14.6%3 Nov 2021
30 Jun 2021$3.7Bup 51.3%4 Aug 2021
31 Mar 2021$3.3Bup 13.0%5 May 2021
31 Dec 2020$3.3Bup 1.7%19 Feb 2021
30 Sep 2020$3.2Bup 3.4%4 Nov 2020
30 Jun 2020$2.4Bdown 21.2%29 Jul 2020
31 Mar 2020$2.9Bup 1.5%29 Apr 2020
31 Dec 2019$3.2B—21 Feb 2020
30 Sep 2019$3.1B—31 Oct 2019
30 Jun 2019$3.1B—31 Jul 2019
31 Mar 2019$2.9B—1 May 2019

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Abbott Laboratories: Diabetes Care revenue · Core Laboratory revenue · Adult Nutritionals revenue · Key Emerging Markets revenue · Pediatric Nutritionals revenue · Cancer Diagnostics revenue · Rapid and Molecular revenue · Electrophysiology revenue · Vascular revenue · Rhythm Management revenue · Rapid Diagnostics revenue · Structural Heart revenue · Heart Failure revenue · Neuromodulation revenue · Point of Care revenue · Molecular revenue · COVID-19 Testing revenue · Diagnostic Products revenue · Nutritional Products revenue · Established Pharmaceuticals revenue · financial statements

Every KPI and segment of ABT, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.